Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
C.5NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.177.89NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
M.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.333NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.429NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.463NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
U.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.373NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.177.80NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.433NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AN.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.177.28NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.221.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.242NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.160.9NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.449NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.152NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.146NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
D.5NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.81NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.258.24NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.160.11NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.160.10NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.177.71NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.445NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.21 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.160.20NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.160.19NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.160.12NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AT.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.619.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
P.1.12.1 (Gamma)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.160.22NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AZ.2.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.260NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.456NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.160.16NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.4.16 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.1.22NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.177.70NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.177.42NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.428NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.374NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.63 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.377NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.258.15NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.298NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
C.30.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.177.76NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.258.11NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used